All News about Gilead Sciences
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Via Benzinga
Exposures
Product Safety
$1000 Invested In This Stock 20 Years Ago Would Be Worth $11,000 Today
February 23, 2024
Via Benzinga
Via Benzinga
From Brodsky & Smith LLC
Via GlobeNewswire
Via Talk Markets
Gilead Sciences to Present at Upcoming Investor Conferences
February 20, 2024
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|